Zoya Technologies has made a groundbreaking announcement at WHX Dubai by launching ZoyeMed 3.0, an edge-native clinical terminal that aims to revolutionize autonomous healthcare delivery. This innovative system combines advanced on-device artificial intelligence with cutting-edge multimodal sensing and point-of-care testing. Designed for both primary and acute care settings, ZoyeMed 3.0 enables high-quality diagnostic capabilities without the need for constant cloud connectivity, making it a game-changer in the healthcare industry.

Introducing a New Era of Healthcare Innovation

ZoyeMed 3.0 stands out as a monumental leap from its predecessors, featuring a closed-loop, edge-first architecture that shifts the focus from merely establishing a dense clinical sensorium to integrating real-time safety and triage alongside complex reasoning. This architecture allows for effective healthcare delivery even in challenging situations, such as areas with limited bandwidth or staffing shortages. The system’s ability to generate longitudinal models over time enhances both efficiency and patient outcomes, ensuring care remains accessible under various conditions.

Global Deployment and Strategic Partnerships

Since the rollout of ZoyeMed 1.0 in 2025, Zoya Technologies has successfully distributed 44 units across different regions, particularly in Mexico, where they are part of an extensive contract for up to 300 units. Similarly, in Colombia, agreements have been finalized for 64 units per year over the next three years. The first ZoyeMed 3.0 unit has already begun its journey to Bogotá, where it will undergo pilot testing, further solidifying Zoya’s commitment to expanding its footprint in international healthcare markets.

Transforming Clinical Infrastructure

Unlike traditional telemedicine platforms and AI assistants that complement existing hospital systems, ZoyeMed 3.0 operates as a compact healthcare infrastructure. It integrates diagnostics, support for clinical decision-making, and follow-up procedures into a single unit available on-site. Designed to alleviate the cognitive burden on healthcare providers, the system aims to offer consistent, protocol-based care on a larger scale, ultimately improving access and efficiency in healthcare delivery.

Future Prospects and Global Impact

Dr. Syed Sabahat Azim, CEO of Zoya Technologies, emphasized the importance of proximity to patient care. He stated, “ZoyeMed 3.0 moves clinical intelligence closer to the patient,” highlighting its capacity to function reliably even in areas with limited connectivity. Following its debut at WHX Dubai, Zoya Technologies has plans for a phased rollout of ZoyeMed 3.0 across key regions, including Latin America, the Middle East, and South Asia. This forward-thinking strategy aims to broaden access to autonomous healthcare solutions, empowering communities and healthcare systems worldwide.

Zoya Technologies is dedicated to developing advanced technological infrastructure aimed at enhancing real-world service delivery. With ZoyeMed 3.0, the company is setting the stage for a new standard in healthcare, emphasizing the significance of edge-native systems capable of transforming patient care through innovative applications. By pioneering this shift, Zoya is poised to make a substantial impact on the healthcare landscape in both developed and emerging markets.